By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab automation company Tecan and ForteBio have partnered to integrate their liquid handling and robotics workstation technologies to provide label-free assays for use in drug discovery and bioprocess research.

The companies have worked together to integrate ForteBio's Octet 384 platform, which includes the RED 384 and the QK384, on Tecan's Freedom EVO liquid handling workstation, Tecan said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."